Lantus solostar 100 unit/ML 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1PZV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,009
Award facts
- Contract value 100% obligated
- $1,008.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,008.75 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The award was made on a firm fixed-price basis with no set-aside designation, indicating full and open competition. Performance will be completed by January 12, 2026, with fulfillment based in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen has established itself as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, consistently delivering prescription medications, medical devices, and specialized healthcare commodities to military treatment facilities and veteran healthcare programs. The company's extensive portfolio with DLA covers multiple therapeutic domains including diabetes management, neurological treatments, pain management, and other specialty pharmaceuticals. This particular delivery order for insulin represents a routine transaction within the company's broader federal pharmaceutical distribution operations, supporting the ongoing medical supply needs of the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26F1PZV?
SPE2DR26F1PZV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F1PZV worth?
The government has obligated $1,009 on SPE2DR26F1PZV.
Is contract SPE2DR26F1PZV an order under another contract?
Yes. SPE2DR26F1PZV is a delivery order under SPE2DR25D3108, an indefinite delivery contract.
Was contract SPE2DR26F1PZV competed?
The extent of competition for SPE2DR26F1PZV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award